Anesthetic interactions of midazolam and fentanyl: is there acute tolerance to the opioid?
The anesthetic effects and interactions of midazolam and fentanyl were determined in terms of their reduction of enflurane MAC in dogs, and the effects of their specific antagonists were also investigated. Control enflurane MAC was determined by the tail clamp method in 18 mongrel dogs. Each animal...
Gespeichert in:
Veröffentlicht in: | Anesthesiology (Philadelphia) 1989-04, Vol.70 (4), p.667-671 |
---|---|
Hauptverfasser: | , , , |
Format: | Artikel |
Sprache: | eng |
Schlagworte: | |
Online-Zugang: | Volltext |
Tags: |
Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
|
container_end_page | 671 |
---|---|
container_issue | 4 |
container_start_page | 667 |
container_title | Anesthesiology (Philadelphia) |
container_volume | 70 |
creator | SCHWIEGER, I. M HALL, R. I SZIAM, F HUG, C. C. JR |
description | The anesthetic effects and interactions of midazolam and fentanyl were determined in terms of their reduction of enflurane MAC in dogs, and the effects of their specific antagonists were also investigated. Control enflurane MAC was determined by the tail clamp method in 18 mongrel dogs. Each animal then received an iv loading dose of midazolam followed by a constant infusion at 9.6 micrograms.kg-1.min-1 designed to produce a stable enflurane MAC reduction of approximately 40%, and enflurane MAC was determined following a 60-min observation period during which time the midazolam concentration in plasma stabilized. Fentanyl was then administered in a series of three incremental loading doses (15, 30, and 225 micrograms/kg) and infusions (0.05, 0.2, and 3.2 micrograms.kg-1.min-1) designed to produce enflurane MAC reductions of 30%, 50%, and 65%, respectively. Enflurane MAC was again determined following a 60-min observation period for each new infusion. In nine dogs after the fourth determination of enflurane MAC, fentanyl was discontinued and 1 mg/kg naloxone was administered iv every 10 min until enflurane MAC was determined for the last time. In the other nine dogs, midazolam was discontinued and 1.5 mg/kg flumazenil (RO 15-1788) was administered and enflurane MAC determined for the last time. The midazolam concentration in plasma remained stable at 414 +/- 134 ng/ml throughout the study, and in the absence of fentanyl reduced enflurane MAC by 40 +/- 10% (mean +/- SD). The addition of fentanyl produced significant further reductions in enflurane MAC. |
doi_str_mv | 10.1097/00000542-198904000-00021 |
format | Article |
fullrecord | <record><control><sourceid>pubmed_pasca</sourceid><recordid>TN_cdi_pubmed_primary_2494910</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>2494910</sourcerecordid><originalsourceid>FETCH-LOGICAL-p235t-384ace1a215740b46c5ca38148bd28d1be556d690347816d83b362ab5d5b68493</originalsourceid><addsrcrecordid>eNo9T8lKA0EQbUSJMfoJQh-8jva-eJEQ3CDgRS9eQm-DLTM9w3TnEL_eHgwWFFWv3ntFFQAQo1uMtLxDc3BGGqyVRqyCpibBJ2CJOVENxpKfgmWd0YYiQs7BRc7fFUpO1QIsCNNMY7QEn-sUcvkKJToYUwmTcSUOKcOhhX305mfoTA9N8rANqZh06O5hzLA6pgCN25cAy9BVW3JzNxNwGOMQ_cMlOGtNl8PVsa7Ax9Pj--al2b49v27W22YklJeGKmZcwIZgLhmyTDjuDFWYKeuJ8tgGzoUXGlEmFRZeUUsFMZZ7boVimq7A9d_ecW_74HfjFHszHXbHHyt_c-RNdqZr51tj_pdJLJQmkv4CoOBhYg</addsrcrecordid><sourcetype>Index Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype></control><display><type>article</type><title>Anesthetic interactions of midazolam and fentanyl: is there acute tolerance to the opioid?</title><source>MEDLINE</source><source>Journals@Ovid Complete</source><source>EZB-FREE-00999 freely available EZB journals</source><creator>SCHWIEGER, I. M ; HALL, R. I ; SZIAM, F ; HUG, C. C. JR</creator><creatorcontrib>SCHWIEGER, I. M ; HALL, R. I ; SZIAM, F ; HUG, C. C. JR</creatorcontrib><description>The anesthetic effects and interactions of midazolam and fentanyl were determined in terms of their reduction of enflurane MAC in dogs, and the effects of their specific antagonists were also investigated. Control enflurane MAC was determined by the tail clamp method in 18 mongrel dogs. Each animal then received an iv loading dose of midazolam followed by a constant infusion at 9.6 micrograms.kg-1.min-1 designed to produce a stable enflurane MAC reduction of approximately 40%, and enflurane MAC was determined following a 60-min observation period during which time the midazolam concentration in plasma stabilized. Fentanyl was then administered in a series of three incremental loading doses (15, 30, and 225 micrograms/kg) and infusions (0.05, 0.2, and 3.2 micrograms.kg-1.min-1) designed to produce enflurane MAC reductions of 30%, 50%, and 65%, respectively. Enflurane MAC was again determined following a 60-min observation period for each new infusion. In nine dogs after the fourth determination of enflurane MAC, fentanyl was discontinued and 1 mg/kg naloxone was administered iv every 10 min until enflurane MAC was determined for the last time. In the other nine dogs, midazolam was discontinued and 1.5 mg/kg flumazenil (RO 15-1788) was administered and enflurane MAC determined for the last time. The midazolam concentration in plasma remained stable at 414 +/- 134 ng/ml throughout the study, and in the absence of fentanyl reduced enflurane MAC by 40 +/- 10% (mean +/- SD). The addition of fentanyl produced significant further reductions in enflurane MAC.</description><identifier>ISSN: 0003-3022</identifier><identifier>EISSN: 1528-1175</identifier><identifier>DOI: 10.1097/00000542-198904000-00021</identifier><identifier>PMID: 2494910</identifier><identifier>CODEN: ANESAV</identifier><language>eng</language><publisher>Hagerstown, MD: Lippincott</publisher><subject>Anesthesia, Inhalation ; Anesthetics. Neuromuscular blocking agents ; Animals ; Biological and medical sciences ; Dogs ; Drug Interactions ; Enflurane ; Fentanyl - pharmacology ; Flumazenil - pharmacology ; Male ; Medical sciences ; Midazolam - pharmacology ; Naloxone - pharmacology ; Neuropharmacology ; Pharmacology. Drug treatments ; Pulmonary Alveoli ; Respiration</subject><ispartof>Anesthesiology (Philadelphia), 1989-04, Vol.70 (4), p.667-671</ispartof><rights>1989 INIST-CNRS</rights><lds50>peer_reviewed</lds50><woscitedreferencessubscribed>false</woscitedreferencessubscribed></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><link.rule.ids>314,780,784,27924,27925</link.rule.ids><backlink>$$Uhttp://pascal-francis.inist.fr/vibad/index.php?action=getRecordDetail&idt=7168927$$DView record in Pascal Francis$$Hfree_for_read</backlink><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/2494910$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>SCHWIEGER, I. M</creatorcontrib><creatorcontrib>HALL, R. I</creatorcontrib><creatorcontrib>SZIAM, F</creatorcontrib><creatorcontrib>HUG, C. C. JR</creatorcontrib><title>Anesthetic interactions of midazolam and fentanyl: is there acute tolerance to the opioid?</title><title>Anesthesiology (Philadelphia)</title><addtitle>Anesthesiology</addtitle><description>The anesthetic effects and interactions of midazolam and fentanyl were determined in terms of their reduction of enflurane MAC in dogs, and the effects of their specific antagonists were also investigated. Control enflurane MAC was determined by the tail clamp method in 18 mongrel dogs. Each animal then received an iv loading dose of midazolam followed by a constant infusion at 9.6 micrograms.kg-1.min-1 designed to produce a stable enflurane MAC reduction of approximately 40%, and enflurane MAC was determined following a 60-min observation period during which time the midazolam concentration in plasma stabilized. Fentanyl was then administered in a series of three incremental loading doses (15, 30, and 225 micrograms/kg) and infusions (0.05, 0.2, and 3.2 micrograms.kg-1.min-1) designed to produce enflurane MAC reductions of 30%, 50%, and 65%, respectively. Enflurane MAC was again determined following a 60-min observation period for each new infusion. In nine dogs after the fourth determination of enflurane MAC, fentanyl was discontinued and 1 mg/kg naloxone was administered iv every 10 min until enflurane MAC was determined for the last time. In the other nine dogs, midazolam was discontinued and 1.5 mg/kg flumazenil (RO 15-1788) was administered and enflurane MAC determined for the last time. The midazolam concentration in plasma remained stable at 414 +/- 134 ng/ml throughout the study, and in the absence of fentanyl reduced enflurane MAC by 40 +/- 10% (mean +/- SD). The addition of fentanyl produced significant further reductions in enflurane MAC.</description><subject>Anesthesia, Inhalation</subject><subject>Anesthetics. Neuromuscular blocking agents</subject><subject>Animals</subject><subject>Biological and medical sciences</subject><subject>Dogs</subject><subject>Drug Interactions</subject><subject>Enflurane</subject><subject>Fentanyl - pharmacology</subject><subject>Flumazenil - pharmacology</subject><subject>Male</subject><subject>Medical sciences</subject><subject>Midazolam - pharmacology</subject><subject>Naloxone - pharmacology</subject><subject>Neuropharmacology</subject><subject>Pharmacology. Drug treatments</subject><subject>Pulmonary Alveoli</subject><subject>Respiration</subject><issn>0003-3022</issn><issn>1528-1175</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>1989</creationdate><recordtype>article</recordtype><sourceid>EIF</sourceid><recordid>eNo9T8lKA0EQbUSJMfoJQh-8jva-eJEQ3CDgRS9eQm-DLTM9w3TnEL_eHgwWFFWv3ntFFQAQo1uMtLxDc3BGGqyVRqyCpibBJ2CJOVENxpKfgmWd0YYiQs7BRc7fFUpO1QIsCNNMY7QEn-sUcvkKJToYUwmTcSUOKcOhhX305mfoTA9N8rANqZh06O5hzLA6pgCN25cAy9BVW3JzNxNwGOMQ_cMlOGtNl8PVsa7Ax9Pj--al2b49v27W22YklJeGKmZcwIZgLhmyTDjuDFWYKeuJ8tgGzoUXGlEmFRZeUUsFMZZ7boVimq7A9d_ecW_74HfjFHszHXbHHyt_c-RNdqZr51tj_pdJLJQmkv4CoOBhYg</recordid><startdate>19890401</startdate><enddate>19890401</enddate><creator>SCHWIEGER, I. M</creator><creator>HALL, R. I</creator><creator>SZIAM, F</creator><creator>HUG, C. C. JR</creator><general>Lippincott</general><scope>IQODW</scope><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope></search><sort><creationdate>19890401</creationdate><title>Anesthetic interactions of midazolam and fentanyl: is there acute tolerance to the opioid?</title><author>SCHWIEGER, I. M ; HALL, R. I ; SZIAM, F ; HUG, C. C. JR</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-p235t-384ace1a215740b46c5ca38148bd28d1be556d690347816d83b362ab5d5b68493</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>1989</creationdate><topic>Anesthesia, Inhalation</topic><topic>Anesthetics. Neuromuscular blocking agents</topic><topic>Animals</topic><topic>Biological and medical sciences</topic><topic>Dogs</topic><topic>Drug Interactions</topic><topic>Enflurane</topic><topic>Fentanyl - pharmacology</topic><topic>Flumazenil - pharmacology</topic><topic>Male</topic><topic>Medical sciences</topic><topic>Midazolam - pharmacology</topic><topic>Naloxone - pharmacology</topic><topic>Neuropharmacology</topic><topic>Pharmacology. Drug treatments</topic><topic>Pulmonary Alveoli</topic><topic>Respiration</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>SCHWIEGER, I. M</creatorcontrib><creatorcontrib>HALL, R. I</creatorcontrib><creatorcontrib>SZIAM, F</creatorcontrib><creatorcontrib>HUG, C. C. JR</creatorcontrib><collection>Pascal-Francis</collection><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><jtitle>Anesthesiology (Philadelphia)</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>SCHWIEGER, I. M</au><au>HALL, R. I</au><au>SZIAM, F</au><au>HUG, C. C. JR</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Anesthetic interactions of midazolam and fentanyl: is there acute tolerance to the opioid?</atitle><jtitle>Anesthesiology (Philadelphia)</jtitle><addtitle>Anesthesiology</addtitle><date>1989-04-01</date><risdate>1989</risdate><volume>70</volume><issue>4</issue><spage>667</spage><epage>671</epage><pages>667-671</pages><issn>0003-3022</issn><eissn>1528-1175</eissn><coden>ANESAV</coden><abstract>The anesthetic effects and interactions of midazolam and fentanyl were determined in terms of their reduction of enflurane MAC in dogs, and the effects of their specific antagonists were also investigated. Control enflurane MAC was determined by the tail clamp method in 18 mongrel dogs. Each animal then received an iv loading dose of midazolam followed by a constant infusion at 9.6 micrograms.kg-1.min-1 designed to produce a stable enflurane MAC reduction of approximately 40%, and enflurane MAC was determined following a 60-min observation period during which time the midazolam concentration in plasma stabilized. Fentanyl was then administered in a series of three incremental loading doses (15, 30, and 225 micrograms/kg) and infusions (0.05, 0.2, and 3.2 micrograms.kg-1.min-1) designed to produce enflurane MAC reductions of 30%, 50%, and 65%, respectively. Enflurane MAC was again determined following a 60-min observation period for each new infusion. In nine dogs after the fourth determination of enflurane MAC, fentanyl was discontinued and 1 mg/kg naloxone was administered iv every 10 min until enflurane MAC was determined for the last time. In the other nine dogs, midazolam was discontinued and 1.5 mg/kg flumazenil (RO 15-1788) was administered and enflurane MAC determined for the last time. The midazolam concentration in plasma remained stable at 414 +/- 134 ng/ml throughout the study, and in the absence of fentanyl reduced enflurane MAC by 40 +/- 10% (mean +/- SD). The addition of fentanyl produced significant further reductions in enflurane MAC.</abstract><cop>Hagerstown, MD</cop><pub>Lippincott</pub><pmid>2494910</pmid><doi>10.1097/00000542-198904000-00021</doi><tpages>5</tpages></addata></record> |
fulltext | fulltext |
identifier | ISSN: 0003-3022 |
ispartof | Anesthesiology (Philadelphia), 1989-04, Vol.70 (4), p.667-671 |
issn | 0003-3022 1528-1175 |
language | eng |
recordid | cdi_pubmed_primary_2494910 |
source | MEDLINE; Journals@Ovid Complete; EZB-FREE-00999 freely available EZB journals |
subjects | Anesthesia, Inhalation Anesthetics. Neuromuscular blocking agents Animals Biological and medical sciences Dogs Drug Interactions Enflurane Fentanyl - pharmacology Flumazenil - pharmacology Male Medical sciences Midazolam - pharmacology Naloxone - pharmacology Neuropharmacology Pharmacology. Drug treatments Pulmonary Alveoli Respiration |
title | Anesthetic interactions of midazolam and fentanyl: is there acute tolerance to the opioid? |
url | https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2024-12-30T22%3A46%3A55IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-pubmed_pasca&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Anesthetic%20interactions%20of%20midazolam%20and%20fentanyl:%20is%20there%20acute%20tolerance%20to%20the%20opioid?&rft.jtitle=Anesthesiology%20(Philadelphia)&rft.au=SCHWIEGER,%20I.%20M&rft.date=1989-04-01&rft.volume=70&rft.issue=4&rft.spage=667&rft.epage=671&rft.pages=667-671&rft.issn=0003-3022&rft.eissn=1528-1175&rft.coden=ANESAV&rft_id=info:doi/10.1097/00000542-198904000-00021&rft_dat=%3Cpubmed_pasca%3E2494910%3C/pubmed_pasca%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_id=info:pmid/2494910&rfr_iscdi=true |